Awareness of Hepatitis C Virus Seropositivity and Chronic Infection in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

被引:0
作者
Mark H. Kuniholm
Molly Jung
Julia Del Amo
Gregory A. Talavera
Bharat Thyagarajan
Ronald C. Hershow
Oriana M. Damas
Robert C. Kaplan
机构
[1] Albert Einstein College of Medicine,Department of Epidemiology and Population Health
[2] Instituto de Salud Carlos III,National Centre of Epidemiology
[3] San Diego State University,Institute for Behavioral and Community Health, Graduate School of Public Health
[4] University of Minnesota,Department of Laboratory Medicine and Pathology
[5] University of Illinois School of Public Health,Division of Epidemiology and Biostatistics
[6] University of Miami Miller School of Medicine,Division of Gastroenterology, Department of Medicine
来源
Journal of Immigrant and Minority Health | 2016年 / 18卷
关键词
Hepatitis C virus; Hispanic; Latino; United States; Awareness;
D O I
暂无
中图分类号
学科分类号
摘要
Few population-based studies have assessed awareness of hepatitis C virus (HCV) seropositivity and chronic infection. We report awareness of HCV seropositivity and chronic infection and correlates of awareness in a multi-city (Bronx, Miami, Chicago, and San Diego) community-dwelling population sample of United States (US) Hispanics/Latinos recruited during 2008–2011. Included were 260 HCV-seropositive participants, among whom 190 had chronic HCV. Among those with chronic HCV, 46 % had been told by a doctor that they had liver disease and 32 % had been told that they had HCV-related liver disease. Among those with chronic HCV who also lacked health insurance (37 % of those with chronic HCV), only 8 % had been told that they had HCV-related liver disease. As compared with the uninsured, those with insurance were over five times more likely to be aware of having HCV-related liver disease (44 %). Sex, age, education, city of residence, and birthplace were not associated with HCV awareness. Less than half of Hispanics/Latinos were aware of their HCV chronic infection. Lack of health insurance may be an important barrier to HCV awareness in this population.
引用
收藏
页码:1257 / 1265
页数:8
相关论文
共 49 条
  • [1] Feuerstadt P(2010)Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients Hepatology 51 1137-1143
  • [2] Bunim AL(2014)Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study Lancet 384 1756-1765
  • [3] Garcia H(2012)Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001–2008 Hepatology 55 1652-1661
  • [4] Lawitz E(2012)Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965 MMWR Recomm Rep 61 1-32
  • [5] Sulkowski MS(2013)Screening for hepatitis C virus infection in adults: US Preventive Services Task Force recommendation statement Ann Intern Med 159 349-357
  • [6] Ghalib R(2007)Health care access, use of services, and experiences among undocumented Mexicans and other Latinos Arch Intern Med 167 2354-2360
  • [7] Denniston MM(2014)Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: results from the NHANES 2007–2010 and HCHS/SOL studies J Infect Dis 209 1585-1590
  • [8] Klevens RM(2010)Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos Ann Epidemiol 20 642-649
  • [9] McQuillan GM(2010)Design and implementation of the Hispanic Community Health Study/Study of Latinos Ann Epidemiol 20 629-641
  • [10] Smith BD(1985)Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412-419